A Rapid Test Offers Hope for Community Screening

A $5 rapid test for the coronavirus may be nearly as effective as the slower, more complex polymerase chain reaction test for identifying people who may spread the coronavirus, a novel experiment has found.

The study, conducted by scientists at the University of California, San Francisco, is among the first head-to-head comparisons of a rapid test and the P.C.R. diagnostic tool under real-world conditions.

But the number of participants was comparatively small, and the data have not been peer-reviewed or published. A rapid test still cannot conclusively determine that an individual is not infected; the tests are intended primarily to detect the presence of high levels of the virus, rather than its absence, and are authorized only to evaluate symptomatic people.

At the moment, anyone who has been exposed to the virus should be tested by P.C.R., said Joseph DeRisi, an infectious disease expert at U.C.S.F. and a co-leader of the project.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS: Inside the Fall of the CDC- in depth

Extra safety scrutiny planned as virus vaccine worries grow

Facing public skepticism about rushed COVID-19 vaccines, U.S. health officials are planning extra scrutiny of the first people vaccinated when shots become available — an added safety layer experts call vital.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

People with Type O blood may be less likely to get the coronavirus or develop severe complications-- new studies

Pfizer Says It Won’t Seek Vaccine Authorization Before Mid-November

The chief executive of Pfizer said on Friday that the company would not apply for emergency authorization of its coronavirus vaccine before the third week of November, ruling out President Trump’s assertion that a vaccine would be ready before Election Day on Nov. 3.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Study finds 4 drugs have little to no effect on COVID-19--WHO

Covid in Europe: how countries are tackling second wave

Europe, US reel as virus infections surge at record pace

FDA faults quality control at Lilly plant making Trump-touted COVID drug--Reuters

Proposal to hasten herd immunity to the coronavirus grabs White House attention but appalls top scientists

US warned Nevada not to use Chinese COVID tests from UAE

'Time is running out,' EU warns, urging measures to avoid new lockdowns

FDA approveS 1st drug, Inmazeb, for Ebola

U.S. regulators Wednesday approved the first drug for the treatment of Ebola.

The Food and Drug Administration OK’d the drug developed by Regeneron Pharmaceuticals for treating adults and children. It was tested during an outbreak in Congo that killed nearly 2,300 people before it ended in June.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New reports show coronavirus immunity can last for months

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

OPINON Essay: As Pandemic Rages on, Some Optimism --NYT science writer srter

 ....Clearly, the pandemic has not ended. So far some 215,000 Americans have lost their lives to the coronavirus, and reliable estimates suggest that the number could reach 400,000. Health experts agree that, with stronger leadership, the death toll would have been far lower.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Japan RSS
howdy folks
Page loaded in 1.116 seconds.